Evidence map›Paper›PMID 37441539›Full record

ArticleCurrent research in parasitology & vector-borne diseases2023

Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea

Norbert Mencke, Katrin Blazejak, Gabriele Petry, Hannah Hamburg, Hannah Ringeisen, Tanja N Knoppe, Alta Viljoen, Ashley Smith, Jennifer Spruill

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in parasitology & vector-borne diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Norbert MenckeVetoquinol S.A., 37 rue de la Victoire, 75009, Paris, France.
Katrin BlazejakVetoquinol S.A., 37 rue de la Victoire, 75009, Paris, France.
Gabriele PetryElanco Animal Health, Alfred Nobel Str. 10, 40789, Monheim, Germany.
Hannah HamburgElanco Animal Health, Alfred Nobel Str. 10, 40789, Monheim, Germany.
Hannah RingeisenElanco Animal Health, Alfred Nobel Str. 10, 40789, Monheim, Germany.
Tanja N KnoppeVet Advice, Dornstücken 25, 22607, Hamburg, Germany.
Alta ViljoenClinvet International (Pty) Ltd, PO Box 11186, 9321, Universitas, Bloemfontein, South Africa.
Ashley SmithElanco Animal Health, 2500 Innovation Way, Greenfield, IN, 46140, USA.
Jennifer SpruillElanco Animal Health, 2500 Innovation Way, Greenfield, IN, 46140, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five studies (two dose determination, two dose confirmation, and one speed of flea kill study) were conducted to assess the immediate (therapeutic) efficacy and long-term persistent (preventive) efficacy of a single spot-on application containing the novel acaricide and insecticide tigolaner in combination with emodepside and praziquantel (Felpreva®, Vetoquinol S.A. Lure, France) applied to cats artificially infested with

Indexed as

CatCtenocephalides felisFelpreva ®FleaSpeed of killTigolaner

Identifiers

PMID37441539
PMCPMC10333678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.